Laboratory Tests for Pericarditis Assessment
All patients with suspected pericarditis should have the following first-level laboratory tests: complete blood count with differential, inflammatory markers (CRP and/or ESR), cardiac biomarkers (troponin and CK), renal function, liver function tests, and thyroid function tests 1.
First-Level Laboratory Workup (Required for All Cases)
The 2015 ESC Guidelines establish a clear tiered approach to laboratory evaluation. For every patient presenting with suspected pericarditis, you must order 1:
- Complete blood count with differential - identifies leukocytosis and helps assess for infection or systemic disease
- Inflammatory markers: CRP and/or ESR - essential for diagnosis confirmation, monitoring disease activity, and guiding treatment duration
- Cardiac biomarkers: Troponin and CK - detects concomitant myocarditis (myopericarditis), which affects prognosis and management
- Renal function tests - screens for uremic pericarditis and guides NSAID dosing
- Liver function tests - identifies metabolic causes and monitors for drug toxicity
- Thyroid function (TSH) - screens for myxedema as a cause, particularly in chronic effusions
These tests serve dual purposes: they support the diagnosis (elevated inflammatory markers are common and supportive findings) and identify high-risk features requiring hospitalization and expanded workup 1.
Risk Stratification Determines Further Testing
The presence of high-risk features mandates hospitalization and a comprehensive etiological search 1. Major risk factors include:
- Fever >38°C
- Subacute course (symptoms over days/weeks)
- Large pericardial effusion (>20mm echo-free space)
- Cardiac tamponade
- Failure to respond to aspirin or NSAIDs after 1 week
Minor risk factors include myocarditis, immunosuppression, trauma, and oral anticoagulation.
Second-Level Testing (For High-Risk Patients)
When high-risk features are present, expand laboratory evaluation based on clinical suspicion 1:
For Suspected Autoimmune Disease:
- ANA, ENA, ANCA
- Ferritin if Still's disease suspected
- ACE and 24-hour urinary calcium if sarcoidosis suspected
For Suspected Tuberculosis:
- IGRA testing (QuantiFERON, ELISpot)
- Consider pericardiocentesis for AFB staining, mycobacterial cultures, PCR, and adenosine deaminase (>40 U/L suggests TB)
For Suspected Bacterial Infection:
- Blood cultures before antibiotics - critical timing
- Serology for Coxiella burnetii (Q fever) if epidemiologically relevant
- Serology for Borrelia if Lyme disease suspected
- Pericardiocentesis for aerobic/anaerobic cultures and glucose level
For Suspected Viral Infection:
- PCR for viral genomes (preferred over serology)
- Serology for HCV and HIV
For Suspected Malignancy:
- Pericardiocentesis for cytology (higher volumes improve yield)
- Tumor markers: CEA >5 ng/mL or CYFRA 21-1 >100 ng/mL
For Chronic Effusion:
- TSH and renal function are particularly important
Critical Pitfalls to Avoid
Don't skip inflammatory markers - CRP/ESR are essential for monitoring treatment response and determining when to taper therapy 2, 3. Normalization of CRP guides the tapering schedule.
Don't overlook troponin elevation - this indicates myopericarditis, which carries different prognostic implications but doesn't necessarily change initial anti-inflammatory treatment 1.
Don't perform extensive etiological workup in low-risk patients - when high-risk features are absent, most cases are idiopathic/viral and resolve with standard therapy. Extensive testing has low yield and increases costs without improving outcomes 1, 4.
Don't routinely culture pericardial fluid - bacterial pericarditis is rare (4% culture positivity), and contamination occurs 5 times more frequently than true pathogens 4. Reserve pericardiocentesis for tamponade, suspected bacterial/neoplastic disease, or large symptomatic effusions not responding to therapy.
Concurrent bacteremia and peripheral neutrophilia are the strongest predictors of bacterial pericarditis 4 - if these are absent and the patient is stable, routine pericardiocentesis for culture is not indicated.
Practical Algorithm
Low-risk presentation (no high-risk features) → First-level labs only → Outpatient management with NSAIDs/colchicine
High-risk presentation (any major/minor risk factor) → First-level labs + targeted second-level testing based on clinical suspicion → Hospitalization + consider pericardiocentesis if tamponade, suspected bacterial/neoplastic cause, or large symptomatic effusion
The key is recognizing that most pericarditis in developed countries is idiopathic or viral 1, requiring only basic laboratory confirmation and inflammatory marker monitoring, while reserving extensive testing for patients with clear risk factors or atypical presentations.